Dr. Ranalli’s clinical and academic interests include the treatment of neuroblastoma, primary renal tumors, germ cell malignancies, melanoma, and the use of novel therapies for refractory malignancies. He is the medical director of the Surgical Oncology Clinic and oversees the Embryonal Tumor Program. Dr. Ranalli received his medical degree from the University of Chicago Pritzker School of Medicine. He completed his residency at Children’s Hospital of Philadelphia and his fellowship training at Children’s Memorial Hospital in Chicago. Dr. Ranalli currently leads the therapeutic MIBG program and is the Nationwide Children’s site principal investigator for the children’s oncology group.